Results 181 to 190 of about 112,056 (332)
Objective Assess the performance of serum phosphorylated tau 217 (p‐tau217) and neurofilament light chain (NfL) in predicting risk of cognitive impairment or phenoconversion to dementia in individuals with iRBD. Methods We measured serum p‐tau217 and NfL levels by electrochemiluminescence across 4 polysomnographically confirmed iRBD cohorts (n = 300 ...
Shijun Yan +7 more
wiley +1 more source
Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas [PDF]
Alexandru Saveanu +10 more
openalex +1 more source
Objective Dopaminergic imaging is a key biomarker for both the investigation of the biology of Parkinson's disease and related synucleinopathies and the evaluation of potential therapies in clinical trials. This work presents a harmonized approach for quantifying dopaminergic molecular imaging tracers, such as [123I]ioflupane (dopamine transporter scan
Zhen Fan +174 more
wiley +1 more source
The graphical abstract shows an eco‐friendly approach to fabricating a biodegradable electrochemical sensor. Carbon quantum dot/nickel oxide (CQD/NiO) nanocomposites are synthesized using Aloe arborescens leaf extract, which served as a natural reducing and stabilizing agent.
Nokwanda Ngema +3 more
wiley +1 more source
Allometry correction in semi-quantitative analysis of dopamine transporter SPECT. [PDF]
Buddenkotte T +3 more
europepmc +1 more source
An eco‐friendly, polydopamine‐assisted electroless metallization of phase change microcapsules enables thin silver or nickel coatings that preserve phase‐change functionality and while enhancing thermal diffusivity and thermomechanical performance in flexible epoxy composites.
Giulia Fredi +3 more
wiley +1 more source
Parthenolide acts as a cocaine antagonist in the human dopamine transporter. [PDF]
Pagán OR.
europepmc +1 more source

